Search Results

You searched for : multiplesclerosis

	ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel ... Nov 03
	Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).... Jun 24
	European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European ... Jun 19
	FDA Authorizes Marketing of Device That Can Improve Gait in Multiple Sclerosis Patients FDA is taking an initiative to authorize the marketing of Portable Neuromodulation Stimulator (PoNS) for Multiple Sclerosis patients which can help patients with their motor ... Apr 15
	USFDA approves Rocheâ€™s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis Shorter infusion time will further improve the twice-yearly treatment experience for OCREVUS, the only B-cell therapy for relapsing and primary progressive MS with ... Dec 15
	Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules After Dr Reddy's, Lupin Ltd. also launches Dimethyl Fumarate Delayed-Release Capsules... Oct 06
	Zydus Cadila receives final approval for Dimethyl Fumarate Capsules Dimethyl Fumarate Capsules are indicated for the treatment of multiple sclerosis... Sep 25
	Cipla receives final approval for generic version of Biogen IDEC Inc.â€™s Tecfidera Cipla Limited today announced that it has received final approval for its ANDA for Dimethyl Fumarate Capsules... Sep 25
8 Matching result(s) found!

-Advertisements-

Trending Now
	Maternal and Infant Health in Focus as India Observes World Health Day 2025April 05, 2025
	Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
	MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
	World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
	Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
	Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
	University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
	Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
	Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
	UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
	SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
	Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
	The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
	The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
	KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
	Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
	CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
	World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
	From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
	Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025

Search Results

ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel

Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg

European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

FDA Authorizes Marketing of Device That Can Improve Gait in Multiple Sclerosis Patients

USFDA approves Rocheâ€™s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis

Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules

Zydus Cadila receives final approval for Dimethyl Fumarate Capsules

Cipla receives final approval for generic version of Biogen IDEC Inc.â€™s Tecfidera

Trending Now